Letters sent to healthcare professionals in September 2015

A letter was sent to healthcare professionals about mirabegron for symptomatic treatment of urgency, increased micturition frequency, or urgency incontinence.

In September 2015, a letter was sent to relevant healthcare professionals for mirabegron to inform of a risk of severe hypertension and associated cerebrovascular and cardiac events. Further information is provided in a Drug Safety Update article.

Article citation: Drug Safety Update vol 9 issue 3 October 2015: 2.

Help us improve GOV.UK

Don’t include personal or financial information, eg your National Insurance number or credit card details.